Actively Recruiting
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Led by October 6 University · Updated on 2025-07-31
90
Participants Needed
1
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy
CONDITIONS
Official Title
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Unilateral acute facial palsy with no identifiable cause
You will not qualify if you...
- Recurrent Bell's palsy
- Pregnancy
- Diabetes
- Epilepsy
- Severe hypertension
- Kidney or liver disease
- Gastric or duodenal ulcer
- Acute or chronic ear infections on the affected side
- Recent head injury
- Psychiatric illness
- Any contraindications to corticosteroids
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
October 6 university hospital
Giza, Egypt, 12573
Actively Recruiting
Research Team
E
Engy Wahsh
CONTACT
M
mohamed rez
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here